The Journal of Practical Medicine ›› 2025, Vol. 41 ›› Issue (14): 2250-2257.doi: 10.3969/j.issn.1006-5725.2025.14.019
• Drugs and Clinic Practice • Previous Articles
Xiaomei BAO,Yu LIU,Chengcheng JIN,Luping. WANG()
Received:
2025-04-07
Online:
2025-07-25
Published:
2025-07-29
Contact:
Luping. WANG
E-mail:bxm5639@163.com
CLC Number:
Xiaomei BAO,Yu LIU,Chengcheng JIN,Luping. WANG. Effects of different dose dexmedetomidine combined with sufentanil on perioperative analgesia and sleep quality in patients with oral cancer[J]. The Journal of Practical Medicine, 2025, 41(14): 2250-2257.
Tab.1
Comparison of three groups of general information"
项目 | A组(n = 53) | B组(n = 53) | C组(n = 52) | χ2/F值 | P值 |
---|---|---|---|---|---|
性别/[例(%)] | 0.152 | 0.696 | |||
男 | 28(52.83) | 30(56.60) | 30(57.69) | ||
女 | 25(47.17) | 23(43.40) | 22(42.31) | ||
ASA分级/[例(%)] | 0.152 | 0.696 | |||
Ⅱ级 | 30(56.60) | 28(52.83) | 28(53.85) | ||
Ⅲ级 | 23(43.40) | 25(47.17) | 24(46.15) | ||
年龄/岁 | 48.65 ± 6.27 | 48.58 ± 6.24 | 48.11 ± 6.78 | 0.109 | 0.897 |
体质量指数/(kg/m2) | 22.34 ± 2.21 | 22.31 ± 2.17 | 22.01 ± 2.45 | 0.336 | 0.715 |
手术时间/min | 121.52 ± 10.33 | 122.40 ± 10.21 | 122.89 ± 10.53 | 0.236 | 0.790 |
术中出血量/mL | 70.34 ± 5.66 | 68.52 ± 5.89 | 69.40 ± 5.44 | 1.360 | 0.258 |
麻醉时间/min | 111.52 ± 4.70 | 110.40 ± 4.35 | 110.78 ± 4.36 | 0.859 | 0.426 |
Tab.2
Comparison of stress response indexes among the three groups"
项目 | A组(n = 53) | B组(n = 53) | C组(n = 52) | F值 | P值 |
---|---|---|---|---|---|
BDNF/(μg/L) | |||||
术前12 h | 5.36 ± 1.11 | 5.42 ± 1.16 | 5.40 ± 1.18 | 0.037 | 0.963 |
术后48 h | 3.46 ± 0.78? | 4.33 ± 0.77?& | 4.58 ± 0.70?&# | 32.280 | < 0.001 |
Cor/(μg/L) | |||||
术前12 h | 514.39 ± 25.07 | 516.32 ± 25.06 | 516.77 ± 25.43 | 0.133 | 0.876 |
术后48 h | 119.15 ± 20.32? | 201.88 ± 20.31?& | 208.70 ± 22.52?&# | 295.611 | < 0.001 |
IL-6/(ng/L) | |||||
术前12 h | 19.81 ± 5.76 | 19.74 ± 5.75 | 19.54 ± 5.22 | 0.033 | 0.968 |
术后48 h | 9.25 ± 1.29? | 12.86 ± 2.22?& | 14.12 ± 2.52?&# | 78.244 | < 0.001 |
Tab.3
Comparison of perioperative sedation and analgesia indexes among the three groups"
组别 | BIS | ANI | ||||||
---|---|---|---|---|---|---|---|---|
T0 | T1 | T2 | T3 | T0 | T1 | T2 | T3 | |
A组(n = 53) | 95.55 ± 3.17 | 47.36 ± 9.52? | 58.51 ± 9.17?& | 89.30 ± 4.33?&# | 48.27 ± 3.17 | 50.07 ± 2.07? | 62.12 ± 3.97?& | 75.57 ± 4.77?&# |
B组(n = 53) | 95.43 ± 3.36 | 45.94 ± 7.35? | 55.80 ± 8.23?& | 90.55 ± 6.58?&# | 48.27 ± 3.12 | 50.97 ± 2.00? | 60.07 ± 3.81?& | 71.52 ± 3.77?&# |
C组(n = 52) | 95.12 ± 3.44 | 42.77 ± 5.61? | 52.65 ± 6.33?& | 93.15 ± 5.77?&# | 48.38 ± 3.14 | 50.92 ± 2.85? | 57.92 ± 3.76?& | 68.45 ± 3.64?&# |
F时间 | 125.422 | 158.422 | ||||||
P时间 | < 0.001 | < 0.001 | ||||||
F组间 | 0.588 | 189.533 | ||||||
P组间 | 0.721 | < 0.001 | ||||||
F交互 | 22.122 | 129.521 | ||||||
P交互 | < 0.001 | < 0.001 |
Tab.4
Comparison of pain levels among the three groups"
组别 | 术前 | 术后1 h | 术后6 h | 术后24 h | 术后48 h |
---|---|---|---|---|---|
A组(n = 53) | 2.58 ± 0.45 | 2.27 ± 0.57 | 1.77 ± 0.32* | 1.51 ± 0.17*& | 1.30 ± 0.14*&# |
B组(n = 53) | 2.55 ± 0.42 | 2.23 ± 0.56 | 1.94 ± 0.35* | 1.80 ± 0.23*& | 1.55 ± 0.12*&# |
C组(n = 52) | 2.60 ± 0.45 | 2.26 ± 0.52 | 2.04 ± 0.30* | 1.90 ± 0.20*& | 1.67 ± 0.18*&# |
F时间 | 31.376 | ||||
P时间 | < 0.001 | ||||
F组间 | 62.470 | ||||
P组间 | < 0.001 | ||||
F交互 | 13.879 | ||||
P交互 | < 0.001 |
Tab.5
Comparison of immune function indexes among the three groups"
组别 | 例数 | CD3+ | CD4+ | CD8+ | |||
---|---|---|---|---|---|---|---|
术前 | 术后3 d | 术前 | 术后3 d | 术前 | 术后3 d | ||
A组 | 53 | 43.36 ± 6.11 | 29.67 ± 4.44? | 38.39 ± 5.07 | 25.15 ± 3.32? | 20.81 ± 1.76 | 32.25 ± 5.29? |
B组 | 53 | 43.50 ± 6.71 | 33.47 ± 5.18?& | 38.12 ± 5.06 | 27.88 ± 3.52?& | 20.74 ± 1.75 | 28.56 ± 4.22?& |
C组 | 52 | 43.58 ± 6.05 | 37.33 ± 5.25?&# | 38.32 ± 5.18 | 34.60 ± 3.44?&# | 20.60 ± 1.33 | 25.44 ± 3.16?&# |
F值 | 0.016 | 31.196 | 0.040 | 105.459 | 0.226 | 32.733 | |
P值 | 0.984 | < 0.001 | 0.961 | < 0.001 | 0.798 | < 0.001 |
[1] |
SARODE G, MANIYAR N, SARODE S C, et al. Epidemiologic aspects of oral cancer[J]. Dis Mon,2020,66(12): 100988. doi:10.1016/j.disamonth.2020.100988
doi: 10.1016/j.disamonth.2020.100988 |
[2] |
MCGURK M, CHEGINI S, SCHILLING C, et al. What is the optimum operative approach for the N0 neck in patients with early mouth cancer-a review of current status[J]. Br J Oral Maxillofac Surg,2022,60(7):864-867. doi:10.1016/j.bjoms.2021.08.011
doi: 10.1016/j.bjoms.2021.08.011 |
[3] |
INCHINGOLO A M, DIPALMA G, INCHINGOLO A D, et al. Advancing Postoperative Pain Management in Oral Cancer Patients: A Systematic Review[J]. Pharmaceuticals (Basel),2024,17(4):542. doi:10.3390/ph17040542
doi: 10.3390/ph17040542 |
[4] |
NIE Z B, LI Z H, LU B, et al. Hydromorphone vs sufentanil in patient-controlled analgesia for postoperative pain management: A meta-analysis[J]. Medicine (Baltimore),2022,101(3):e28615. doi:10.1097/md.0000000000028615
doi: 10.1097/md.0000000000028615 |
[5] | 谷梓毓,刘雨,丁怡彤,等. 右美托咪定用于患者自控式睡眠调节对胃肠肿瘤患者术后睡眠障碍的疗效[J]. 中华麻醉学杂志,2024,44(5):609-614. |
[6] | 尚伟,郑家伟. 2019年NCCN口腔口咽癌诊疗指南更新解读[J]. 中国口腔颌面外科杂志,2019,17(6):481-485. |
[7] | 孙兵,车晓明(整理. 视觉模拟评分法(VAS)[J]. 中华神经外科杂志,2012,28(6):645. |
[8] | 杨贵亭,郭向阳,陶立元,等. 镇痛/伤害刺激指数与宫腔镜腰麻后低血压的相关性研究[J]. 中国微创外科杂志,2019,19(3):193-196. |
[9] | 陈丽霞,纪代红,赵巧玉,等. 中文版理查兹-坎贝尔睡眠量表的信效度研究[J]. 中华护理杂志,2016,51(9):1141-1144. |
[10] |
WARNAKULASURIYA S, KUJAN O, AGUIRRE-URIZAR J M,et al. Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer[J]. Oral Dis,2021,27(8):1862-1880. doi:10.1111/odi.13704
doi: 10.1111/odi.13704 |
[11] |
ZHANG W, ZHU H, YE P. Unplanned reoperation after radical surgery for oral cancer: An analysis of risk factors and outcomes[J]. BMC Oral Health,2022,22(1):204. doi:10.1186/s12903-022-02238-7
doi: 10.1186/s12903-022-02238-7 |
[12] |
BROUWER KONING S G, SCHAEFFERS A W M A, SCHATS W,et al. Assessment of the deep resection margin during oral cancer surgery: A systematic review[J]. Eur J Surg Oncol,2021,47(9):2220-2232. doi:10.1016/j.ejso.2021.04.016
doi: 10.1016/j.ejso.2021.04.016 |
[13] | 陶芸生,江昭林,甘泉,等. 不同剂量右美托咪定联合舒芬太尼对全髋关节置换术患者术中及术后的影响[J]. 中国骨与关节杂志,2021,10(7):527-532. |
[14] | 罗莹,韩宏雨,程守全,等. 不同剂量右美托咪定联合舒芬太尼对老年全髋关节置换术患者血流动力学,脑保护效应和T淋巴细胞亚群的影响[J]. 现代生物医学进展,2022,22(10):1869-1874. |
[15] |
KOUSHIK S S, SCHWARTZ R H, CHERKALIN D, et al. A Review of Sublingual Sufentanil Tablet (SST) and its Utility as an Analgesic Agent for Pain Procedures[J]. Curr Pain Headache Rep,2022,26(2):145-149. doi:10.1007/s11916-022-01014-0
doi: 10.1007/s11916-022-01014-0 |
[16] |
FONSECA N M, GUIMARAES G M N, PONTES J P J,et al. Safety and effectiveness of adding fentanyl or sufentanil to spinal anesthesia:Systematic review and meta-analysis of randomized controlled trials[J]. Braz J Anesthesiol,2023,73(2):198-216. doi:10.1016/j.bjane.2021.10.010
doi: 10.1016/j.bjane.2021.10.010 |
[17] | 陈添辉,张莹珊,李集源,等. 右美托咪定辅助术后镇痛对老年患者腹部手术后睡眠质量的影响[J]. 临床麻醉学杂志,2024,40(9):928-932. |
[18] | 侯艳华,张加强,武江霞. 不同麻醉方法对食管癌根治术患者术后睡眠质量的影响[J]. 中华麻醉学杂志,2020,40(4):500-501. |
[19] |
POON W H, LING R R, YANG I X,et al. Dexmedetomidine for adult cardiac surgery:A systematic review, meta-analysis and trial sequential analysis[J]. Anaesthesia,2023,78(3):371-380. doi:10.1111/anae.15947
doi: 10.1111/anae.15947 |
[20] |
LAMSAL R, RATH G P, DUBE S K. Effect of Dexmedetomidine on Dynamic Cerebral Autoregulation in Patients Undergoing Supratentorial Tumor Surgery[J]. Neurol India,2025,73(2):280-285. doi:10.4103/neurol-india.neurol-india-d-24-00131
doi: 10.4103/neurol-india.neurol-india-d-24-00131 |
[21] |
TASBIHGOU S R, BARENDS C R M, ABSALOM A R. The role of dexmedetomidine in neurosurgery[J]. Best Pract Res Clin Anaesthesiol,2021,35(2):221-229. doi:10.1016/j.bpa.2020.10.002
doi: 10.1016/j.bpa.2020.10.002 |
[22] |
OZCAN E, OZCAN F G. Difficult Airway Management in Oromaxillofacial Tumor Surgery: Two Case Reports and Review of the Literature[J]. Indian J Otolaryngol Head Neck Surg, 2025,77(2):1088-1094. doi:10.1007/s12070-024-05274-7
doi: 10.1007/s12070-024-05274-7 |
[23] |
PATIL S, YADALAM P K, HOSMANI J,et al. Modulation of oral cancer and periodontitis using chemotherapeutic agents-A narrative review[J]. Dis Mon,2023,69(1):101348. doi:10.1016/j.disamonth.2022.101348
doi: 10.1016/j.disamonth.2022.101348 |
[24] |
MOLLER M H, ALHAZZANI W, LEWIS K,et al. Use of dexmedetomidine for sedation in mechanically ventilated adult ICU patients:A rapid practice guideline[J]. Intensive Care Med,2022,48(7):801-810. doi:10.1007/s00134-022-06660-x
doi: 10.1007/s00134-022-06660-x |
[25] | BOSCH O G, DORNBIERER D A, BAVATO F,et al. Dexmedetomidine in Psychiatry: Repurposing of its Fast-Acting Anxiolytic, Analgesic and Sleep Modulating Properties[J]. Pharmacopsychiatry,2023,56(2):44-50. |
[26] |
FABBRI M, BERACCI A, MARTONI M,et al. Measuring Subjective Sleep Quality: A Review[J]. Int J Environ Res Public Health,2021,18(3):1082. doi:10.3390/ijerph18031082
doi: 10.3390/ijerph18031082 |
[27] |
RAIMANN F J, ADAM E, STROUHAL U,et al. Dexmedetomidine as adjunct in awake craniotomy-improvement or not?[J]. Anaesthesiol Intensive Ther,2020,52(1):15-22. doi:10.5114/ait.2020.93043
doi: 10.5114/ait.2020.93043 |
[28] |
ZHAO S, WU W, LIN X,et al. Protective effects of dexmedetomidine in vital organ injury: Crucial roles of autophagy[J]. Cell Mol Biol Lett,2022,27(1):34. doi:10.1186/s11658-022-00335-7
doi: 10.1186/s11658-022-00335-7 |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||